Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

4921506J03Rik Inhibitors

Ataxin 7-like 3B (ATXN7L3B) is a protein that, while sharing similarity with ataxin-7, a protein known for its involvement in spinocerebellar ataxia type 7 (SCA7), has its own distinct roles and functions within the cellular milieu. The "like" in its name refers to the homology it shares with ataxin-7, particularly in certain domains that suggest a potential for overlap in function or interaction with similar biological molecules.ATXN7L3B is a lesser-studied member of the ataxin family of proteins, which are characterized by their roles in neurodegenerative diseases and their involvement in various cellular processes, including gene regulation, RNA metabolism, and protein homeostasis. While the specific functions of ATXN7L3B are not as well-defined as those of ataxin-7, it is believed that ATXN7L3B may be implicated in similar pathways, potentially influencing gene expression regulation and chromatin remodeling due to the presence of domains typically associated with these functions.

The protein's structure suggests that it may interact with components of the transcription machinery or chromatin-modifying complexes, implicating it in the control of transcriptional activity. Given its homology with ataxin-7, ATXN7L3B may also be a part of protein complexes that are involved in the regulation of gene expression, possibly through modifying chromatin structure or influencing the transcriptional machinery directly.Though not directly associated with any known neurodegenerative diseases, the study of ATXN7L3B could provide insights into the broader family of ataxin proteins and their roles in cellular homeostasis and disease. As research progresses, determining the specific interactions and pathways that ATXN7L3B is involved in will be crucial for understanding its biological significance and the potential impact of its dysregulation.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Histone deacetylase inhibitor, potentially reducing transcription of certain genes.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA methyltransferase inhibitor, could decrease methylation and affect gene expression.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

Non-nucleoside DNA methyltransferase inhibitor, might lead to demethylation and altered gene expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Another DNA methyltransferase inhibitor, could similarly affect gene expression patterns.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Histone deacetylase inhibitor that can change chromatin structure and gene expression.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

PARP inhibitor, while primarily used for DNA repair, may have off-target effects on gene regulation.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Antitumor antibiotic that can bind to DNA and potentially affect transcription factor binding.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Binds to DNA and can inhibit RNA polymerase action, thereby reducing gene transcription.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Known to inhibit transcriptional activity in various cell types, might affect a range of genes.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor, could indirectly affect protein synthesis and gene expression.